KLK6 and Alzheimer disease: In another study, CSF KLK6 levels did not differ neither between subjective cognitive impairment (n = 43) and AD (n = 43), nor between clinically diagnosed normal controls (n = 58) and clinically diagnosed AD (n = 28) or clinically diagnosed progressive mild cognitive impairment (MCI) (n = 28) [24].